Related Experiment Video
Updated: Aug 4, 2026

Why Quantification Matters: Characterization of Phenotypes at the Drosophila Larval Neuromuscular Junction
Published on: May 12, 2016
Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is
Oliver J Ziff1, Jasmine Harley2, Yiran Wang3
1The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, WC1N 3BG London, UK; National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, WC1N 3BG London, UK.
Abstract:
Amyotrophic lateral sclerosis (ALS) is characterized by nucleocytoplasmic mislocalization of the RNA-binding protein (RBP) TDP-43. However, emerging evidence suggests more widespread mRNA and protein mislocalization. Here, we employed nucleocytoplasmic fractionation, RNA sequencing, and mass spectrometry to investigate the localization of mRNA and protein in induced pluripotent stem cell-derived motor neurons (iPSMNs) from ALS patients with TARDBP and VCP mutations. ALS mutant iPSMNs exhibited extensive nucleocytoplasmic mRNA redistribution, RBP mislocalization, and splicing alterations. Mislocalized proteins exhibited a greater affinity for redistributed transcripts, suggesting a link between RBP mislocalization and mRNA redistribution. Notably, treatment with ML240, a VCP ATPase inhibitor, partially restored mRNA and protein localization in ALS mutant iPSMNs. ML240 induced changes in the VCP interactome and lysosomal localization and reduced oxidative stress and DNA damage. These findings emphasize the link between RBP mislocalization and mRNA redistribution in ALS motor neurons and highlight the therapeutic potential of VCP inhibition.
Insights
Amyotrophic lateral sclerosis (ALS) involves mislocalized proteins and RNA in motor neurons. Inhibiting VCP ATPase with ML240 partially restored normal localization, suggesting a potential therapeutic strategy for ALS.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is linked to the mislocalization of TDP-43, an RNA-binding protein (RBP), between the nucleus and cytoplasm.
- Evidence suggests broader mRNA and protein mislocalization occurs in ALS pathogenesis.
Purpose of the Study:
- To investigate mRNA and protein localization in induced pluripotent stem cell-derived motor neurons (iPSMNs) from ALS patients with TARDBP and VCP mutations.
- To explore the relationship between RBP mislocalization and mRNA redistribution in ALS.
- To assess the therapeutic potential of VCP ATPase inhibition.
Main Methods:
- Nucleocytoplasmic fractionation, RNA sequencing, and mass spectrometry were used to analyze mRNA and protein localization.
- iPSMNs derived from ALS patients with TARDBP and VCP mutations were utilized.
- Treatment with ML240, a VCP ATPase inhibitor, was applied to ALS mutant iPSMNs.
Main Results:
- ALS mutant iPSMNs showed significant nucleocytoplasmic mRNA redistribution, RBP mislocalization, and altered splicing.
- Mislocalized proteins demonstrated increased binding affinity to redistributed transcripts, indicating a connection between RBP and mRNA mislocalization.
- ML240 treatment partially corrected mRNA and protein localization, altered the VCP interactome and lysosomal localization, and reduced oxidative stress and DNA damage.
Conclusions:
- A strong link exists between RBP mislocalization and mRNA redistribution in ALS motor neurons.
- VCP ATPase inhibition represents a promising therapeutic avenue for ALS treatment.
Related Concept Videos
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Regulated mRNA Transport
Regulation of Nuclear Protein Sorting
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Export of Misfolded Proteins out of the ER

